Zijing Chen1, Vincent S Fan2,3, Basia Belza1, Kenneth Pike1, Huong Q Nguyen1,4. 1. 1 School of Nursing and. 2. 3 Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, Washington. 3. 2 Veterans Affairs Puget Sound Health Care System, Seattle, Washington; and. 4. 4 Kaiser Permanente Southern California, Pasadena, California.
Abstract
RATIONALE: Higher social support is associated with a better quality of life and functioning in adults with chronic obstructive pulmonary disease (COPD). OBJECTIVES: To determine the association between structural and functional social support and self-care behaviors in adults with COPD. METHODS: This was a longitudinal study using data from the CASCADE (COPD Activity: Serotonin Transporter, Cytokines, and Depression) study, which was focused on depression and functioning in COPD. Physical activity was measured with a validated accelerometer at baseline, year 1, and year 2. Additional self-care behaviors included pulmonary rehabilitation attendance, smoking status, receipt of influenza and/or pneumococcal vaccinations, and medication adherence. Structural social support indicators included living status, being partnered, number of close friends/relatives, and presence of a family caregiver. Functional social support was measured with the Medical Outcomes Social Support Survey (MOSSS). Mixed-effects and logistic regression models were used. RESULTS: A total of 282 participants with Global Initiative for Chronic Obstructive Lung Disease stage II to IV COPD were included (age, 68 ± 9 yr; 80% men; FEV1% predicted, 45 ± 16). For physical activity, participants who lived with others accrued 903 more steps per day than those who lived alone (95% confidence interval [CI], 373-1,433; P = 0.001); increases in the MOSSS total score were associated with more steps per day (β = 10; 95% CI, 2-18; P = 0.02). The odds of pulmonary rehabilitation participation were more than 11 times higher if an individual had a spouse or partner caregiver compared with not having a caregiver (odds ratio [OR], 11.03; 95% CI, 1.93-62.97; P < 0.01). Higher functional social support (MOSSS total score) was associated with marginally lower odds of smoking (OR, 0.99; 95% CI, 0.98-1.00; P = 0.03) and higher odds of pneumococcal vaccination (OR, 1.02; 95% CI, 1.00-1.03; P = 0.02). Social support was not associated with influenza vaccination or medication adherence. CONCLUSIONS: Structural social support, which was measured by reports of living with others and having a caregiver, was respectively associated with higher levels of physical activity and greater participation in pulmonary rehabilitation in adults with COPD. Our findings reinforce the critical importance of the social environment in shaping patients' success with self-care. Clinical Trial registered with clinicaltrials.gov (NCT01074515).
RATIONALE: Higher social support is associated with a better quality of life and functioning in adults with chronic obstructive pulmonary disease (COPD). OBJECTIVES: To determine the association between structural and functional social support and self-care behaviors in adults with COPD. METHODS: This was a longitudinal study using data from the CASCADE (COPD Activity: Serotonin Transporter, Cytokines, and Depression) study, which was focused on depression and functioning in COPD. Physical activity was measured with a validated accelerometer at baseline, year 1, and year 2. Additional self-care behaviors included pulmonary rehabilitation attendance, smoking status, receipt of influenza and/or pneumococcal vaccinations, and medication adherence. Structural social support indicators included living status, being partnered, number of close friends/relatives, and presence of a family caregiver. Functional social support was measured with the Medical Outcomes Social Support Survey (MOSSS). Mixed-effects and logistic regression models were used. RESULTS: A total of 282 participants with Global Initiative for Chronic Obstructive Lung Disease stage II to IV COPD were included (age, 68 ± 9 yr; 80% men; FEV1% predicted, 45 ± 16). For physical activity, participants who lived with others accrued 903 more steps per day than those who lived alone (95% confidence interval [CI], 373-1,433; P = 0.001); increases in the MOSSS total score were associated with more steps per day (β = 10; 95% CI, 2-18; P = 0.02). The odds of pulmonary rehabilitation participation were more than 11 times higher if an individual had a spouse or partner caregiver compared with not having a caregiver (odds ratio [OR], 11.03; 95% CI, 1.93-62.97; P < 0.01). Higher functional social support (MOSSS total score) was associated with marginally lower odds of smoking (OR, 0.99; 95% CI, 0.98-1.00; P = 0.03) and higher odds of pneumococcal vaccination (OR, 1.02; 95% CI, 1.00-1.03; P = 0.02). Social support was not associated with influenza vaccination or medication adherence. CONCLUSIONS: Structural social support, which was measured by reports of living with others and having a caregiver, was respectively associated with higher levels of physical activity and greater participation in pulmonary rehabilitation in adults with COPD. Our findings reinforce the critical importance of the social environment in shaping patients' success with self-care. Clinical Trial registered with clinicaltrials.gov (NCT01074515).
Authors: Rafael Mesquita; Nienke Nakken; Daisy J A Janssen; Esther H A van den Bogaart; Jeannet M L Delbressine; Johannes M N Essers; Kenneth Meijer; Monique van Vliet; Geeuwke J de Vries; Jean W M Muris; Fabio Pitta; Emiel F M Wouters; Martijn A Spruit Journal: Chest Date: 2017-01-10 Impact factor: 9.410
Authors: Maher R Khdour; Ahmed F Hawwa; Joseph C Kidney; Bronagh M Smyth; James C McElnay Journal: Eur J Clin Pharmacol Date: 2012-04-05 Impact factor: 2.953
Authors: Rachel E Jordan; Saimma Majothi; Nicola R Heneghan; Deirdre B Blissett; Richard D Riley; Alice J Sitch; Malcolm J Price; Elizabeth J Bates; Alice M Turner; Susan Bayliss; David Moore; Sally Singh; Peymane Adab; David A Fitzmaurice; Susan Jowett; Kate Jolly Journal: Health Technol Assess Date: 2015-05 Impact factor: 4.014
Authors: Heleen Demeyer; Chris Burtin; Miek Hornikx; Carlos Augusto Camillo; Hans Van Remoortel; Daniel Langer; Wim Janssens; Thierry Troosters Journal: PLoS One Date: 2016-04-28 Impact factor: 3.240
Authors: Aliza A Panjwani; Joel Erblich; Tracey A Revenson; Hoda J Badr; Alex D Federman; Juan P Wisnivesky Journal: Psychol Health Med Date: 2022-04-03 Impact factor: 3.898
Authors: Panagis Galiatsatos; Han Woo; Laura M Paulin; Amy Kind; Nirupama Putcha; Amanda J Gassett; Christopher B Cooper; Mark T Dransfield; Trisha M Parekh; Gabriela R Oates; R Graham Barr; Alejandro P Comellas; Meilan K Han; Stephen P Peters; Jerry A Krishnan; Wassim W Labaki; Meredith C McCormack; Joel D Kaufman; Nadia N Hansel Journal: Int J Chron Obstruct Pulmon Dis Date: 2020-05-05
Authors: Ane Arbillaga-Etxarri; Elena Gimeno-Santos; Anael Barberan-Garcia; Eva Balcells; Marta Benet; Eulàlia Borrell; Nuria Celorrio; Anna Delgado; Carme Jané; Alicia Marin; Carlos Martín-Cantera; Mónica Monteagudo; Nuria Montellà; Laura Muñoz; Pilar Ortega; Diego A Rodríguez; Robert Rodríguez-Roisin; Pere Simonet; Pere Torán-Monserrat; Jaume Torrent-Pallicer; Pere Vall-Casas; Jordi Vilaró; Judith Garcia-Aymerich Journal: Eur Respir J Date: 2018-10-18 Impact factor: 16.671
Authors: Jonathan Miranda; Danielle Underwood; Miranda Kuepfer-Thomas; Drew Coulson; Andy Chansoo Park; Stacey J Butler; Roger Goldstein; Dina Brooks; Amanda C Everall; Sara J T Guilcher Journal: Health Expect Date: 2020-01-01 Impact factor: 3.377
Authors: Emily S Wan; Rebekah L Goldstein; Vincent S Fan; Huong Q Nguyen; Jaime E Hart; Eric Garshick; Esther H Orr; Immaculata DeVivo; Marilyn L Moy Journal: PLoS One Date: 2019-10-17 Impact factor: 3.240